D
Daniel L. Alkon
Researcher at West Virginia University
Publications - 314
Citations - 14681
Daniel L. Alkon is an academic researcher from West Virginia University. The author has contributed to research in topics: Protein kinase C & Associative learning. The author has an hindex of 61, co-authored 310 publications receiving 14036 citations. Previous affiliations of Daniel L. Alkon include National Institutes of Health & Woods Hole Oceanographic Institution.
Papers
More filters
Journal ArticleDOI
Accelerating the convergence of the back-propagation method
TL;DR: The back-propagation algorithm described by Rumelhart et al. (1986) can greatly accelerate convergence as discussed by the authors, however, in many applications, the number of iterations required before convergence can be large.
Journal ArticleDOI
Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats.
TL;DR: The findings suggest that IR may participate in memory processing through activation of its receptor Tyr kinase activity, and they suggest possible engagement of Shc/Grb-2/Ras/mitogen-activated protein kinase cascades.
Journal ArticleDOI
Insulin and the insulin receptor in experimental models of learning and memory
TL;DR: Emerging evidence has suggested that insulin signaling plays a role in synaptic plasticity by modulating activities of excitatory and inhibitory receptors such as glutamate and GABA receptors, and by triggering signal transduction cascades leading to alteration of gene expression required for long-term memory consolidation.
Journal ArticleDOI
Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.
Etsuro Ito,Kotaro Oka,Rene Etcheberrigaray,Thomas J. Nelson,Donna L. McPhie,Beth Tofel-Grehl,Gary E. Gibson,Daniel L. Alkon +7 more
TL;DR: Bombesin-induced Ca2+ release, which is inositol trisphosphate-mediated, is shown here to be greatly enhanced in AD fibroblasts compared with fibroBlasts from control groups, suggesting that the differences in bombesin and bradykinin responses in fibro Blasts and perhaps other cell types are likely to be due to alteration of inositl tr isphosphates-mediated release of intracellular Ca2+.
Journal ArticleDOI
Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.
Rene Etcheberrigaray,Mathew Tan,Ilse Dewachter,Cuno Kuiperi,Ingrid Van der Auwera,Stefaan Wera,Lixin Qiao,Barry Bank,Thomas J. Nelson,Alan P. Kozikowski,Fred Van Leuven,Daniel L. Alkon +11 more
TL;DR: Bryostatin 1 at subnanomolar concentrations dramatically enhances the secretion of the alpha-secretase product sAPP alpha in fibroblasts from AD patients, corroborate PKC and its activation as a potentially important means of ameliorating AD pathophysiology and perhaps cognitive impairment.